Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.

[1]  A. Hall,et al.  DLC1: a significant GAP in the cancer genome. , 2008, Genes & development.

[2]  Peilin Huang,et al.  Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. , 2008, Oncology reports.

[3]  J. Sung,et al.  Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus , 2008, Journal of Virology.

[4]  Hagit Shatkay,et al.  F-SNP: computationally predicted functional SNPs for disease association studies , 2007, Nucleic Acids Res..

[5]  Jung Weon Lee,et al.  DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. , 2007, Biochemical and biophysical research communications.

[6]  Gangqiao Zhou,et al.  Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk , 2007, Gut.

[7]  Zhijian Yao,et al.  Estrogen Receptor α Polymorphisms Associated With Susceptibility to Hepatocellular Carcinoma in Hepatitis B Virus Carriers , 2006 .

[8]  I. Ng,et al.  Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. , 2005, Cancer research.

[9]  Y. Kim,et al.  Single Nucleotide Polymorphisms Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection , 2005, Intervirology.

[10]  K. McGlynn,et al.  Epidemiology and natural history of hepatocellular carcinoma. , 2005, Best practice & research. Clinical gastroenterology.

[11]  Zhijian Yao,et al.  Association of estrogen receptor α polymorphisms with susceptibility to chronic hepatitis B virus infection , 2004 .

[12]  Yuh-Shan Jou,et al.  Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. , 2004, Cancer research.

[13]  S. Thorgeirsson,et al.  Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells , 2004, Oncogene.

[14]  Zhijian Yao,et al.  Variants in TNFRSF5 locus and association analysis with Hepatitis B virus (HBV) infection , 2004, Human mutation.

[15]  I. Ng,et al.  Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. , 2003, Cancer research.

[16]  N. Laird,et al.  Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.

[17]  J. Carpten,et al.  Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. , 2003, Mutation research.

[18]  S. Thorgeirsson,et al.  DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma. , 2003, International journal of oncology.

[19]  Chien-Jen Chen,et al.  Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology , 2002, Hepatology.

[20]  J. Fraumeni,et al.  International trends and patterns of primary liver cancer , 2001, International journal of cancer.

[21]  I. Ng,et al.  DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. , 2000, Cancer research.

[22]  Y. Emori,et al.  Morphological Changes and Detachment of Adherent Cells Induced by p122, a GTPase-activating Protein for Rho* , 1999, The Journal of Biological Chemistry.

[23]  S. Thorgeirsson,et al.  Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. , 1998, Cancer research.

[24]  A. Valleron,et al.  Trends in primary liver cancer , 1998, The Lancet.

[25]  Chien-Jen Chen,et al.  Epidemiological characteristics and risk factors of hepatocellular carcinoma , 1997, Journal of gastroenterology and hepatology.

[26]  小松 裕和.  Impact of breastfeeding on body weight of preschool children in a rural area of Japan : population-based cross-sectional study , 2009 .

[27]  Zhijian Yao,et al.  Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. , 2006, Gastroenterology.

[28]  S. Thorgeirsson,et al.  Genetic profiling of human hepatocellular carcinoma. , 2005, Seminars in liver disease.

[29]  Zhijian Yao,et al.  Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. , 2004, Hepatology.

[30]  I. Ng,et al.  Genetic and Epigenetic Alterations of DLC1 Gene in Hepatocellular Carcinoma , 2003 .

[31]  I. Ng,et al.  Advances in Brief DLC1 Is Deleted in Primary Hepatocellular Carcinoma and Exerts Inhibitory Effects on the Proliferation of Hepatoma Cell Lines with Deleted DLC1 1 , 2000 .

[32]  Y. Nakamura,et al.  Isolation of 45 exon-like fragments from 8p22-->p21.3, a region that is commonly deleted in hepatocellular, colorectal, and non-small cell lung carcinomas. , 1996, Cytogenetics and cell genetics.